QIAGEN's QuantiFERON-TB Passes Milestone of 60 Million Tests in Global Fight against Tuberculosis, Current Annual Run Rate Exceeds 12 Million Tests

New automation options highlighted for QuantiFERON-TB Gold Plus at ECCMID 2019 to increase efficiency and improve ease of adoption for modern gold standard latent TB test QIAGEN N.V. (NYSE: QGEN; ...